July 2015 FDA Recall Bupropion Hydrochloride by Sun Pharma Global Fze
D-1345-2015 - Failed Dissolution Specification

This Class III drug recall was voluntarily initiated by Sun Pharma Global Fze on July 17, 2015 for the product Bupropion Hydrochloride. The FDA reported the reason for recall as failed dissolution specification. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-1345-2015

Reason for Recall
Failed Dissolution Specification: During analysis of the 18 month long term stability testing, it was noticed that the drug release results at the 4 hour time point are not meeting specifications.
Initiated
07-17-2015
Reported
08-26-2015
Quantity
35,235 bottles

Recall Profile & Regulatory Data

Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
Sun Pharma Global Fze
Nationwide and Puerto Rico
buPROPion Hydrochloride Extended-¿release Tablets USP (SR), 200 mg, Twice-A-Day, Rx Only, 60 count Bottle, Distributed by: Sun Pharmaceutical Industries Inc. Cranbury, NJ 08512, Manufactured By: Sun Pharmaceutical Ind. Ltd., Halol Baroda Highway, Halol 389 350, Gujarat, India, NDC 47335-738-86

Batch or Lot Expiration Information

Lot# s: JKM4152A, JKM4737A, JKM5270A, Exp 08/2015